PepGen logo

PepGen

66 people · 0 jobs

Driven by its proprietary Enhanced Delivery Oligonucleotide (EDO) platform, PepGen is creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic diseases, with an initial focus on neuromuscular diseases.

Industries

Employees

11-50

Links


Org chart

Collapse

Board & advisors


Teams


Offices